ArticleEBioMedicine2019

Pretreatment anti-thyroid autoantibodies indicate increased risk for thyroid autoimmunity secondary to alemtuzumab: A prospective cohort study.

Tobias Ruck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.